Oramed Pharmaceuticals Inc. (ORMP) SEC Filings — 2025
19 SEC filings for Oramed Pharmaceuticals Inc. (ORMP) in 2025.
Filings
- Oramed Pharmaceuticals Reports Director/Officer Changes — 8-K · Dec 31, 2025
- Oramed Pharmaceuticals Files 8-K Report — 8-K · Dec 31, 2025
- Oramed Pharmaceuticals Files 8-K on Material Agreement — 8-K · Nov 17, 2025
- Oramed Swings to Profit on Soaring Financial Income, Strategic Investments — 10-Q · Nov 13, 2025
- Oramed Pharmaceuticals Terminates Material Agreement — 8-K · Oct 24, 2025
- Oramed Pharmaceuticals Files 8-K Report — 8-K · Oct 6, 2025
- Oramed Pharmaceuticals Reports Director/Officer Changes & Shareholder Votes — 8-K · Aug 21, 2025
- Oramed's Q2 Net Income Jumps Amid JV Delays, Cash Drains — 10-Q · Aug 14, 2025
- Oramed Pharmaceuticals Files 8-K: Material Agreement — 8-K · Jul 23, 2025
- Oramed Files 10-K/A, Confirms Compliance for FY24 — 10-K/A · Jul 16, 2025
- Oramed Pharmaceuticals Relocates HQ, Updates Contact Info — 8-K · May 21, 2025
- Oramed Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 15, 2025
- Oramed Pharmaceuticals Enters Material Definitive Agreement — 8-K · Apr 28, 2025
- Oramed Pharmaceuticals Files 2024 Annual Report — 10-K · Mar 27, 2025
- Oramed Pharmaceuticals Files 8-K with Material Agreement — 8-K · Mar 3, 2025
- Oramed Pharmaceuticals Enters Material Definitive Agreement — 8-K · Feb 27, 2025
- Oramed Pharmaceuticals Files 8-K with Material Agreement — 8-K · Feb 11, 2025
- Oramed Pharmaceuticals Files 8-K for Material Agreement — 8-K · Jan 22, 2025
- Oramed Pharmaceuticals Files 8-K with Material Agreement — 8-K · Jan 3, 2025